WHAT IS DIGIPHARM?!

The Digipharm PLATFORM is a single globally-sourced healthcare service platform for the public that begins with free Human Doctor-AI assisted Video Telemedicine service (Digipharm APP) already in use in 20 countries by thousands of users and an associated suite of AI assisted tools and social network for the medical community (Digipharm for Doctors).

Problem
Health care around the world do not have the relevant infrastructure to track and implement pricing that have innovative models, they are mostly reluctant to take in such policies that are innovative. Their systems are most often required to make hard decisions of whether to provide access to patients as opposed to costly pharmacological therapies while taking into cognizance their limited resources.
• Inability of patients adherence in real time
• Patients privacy
• Healthcare systems that are fragmented
• The inability to use a one size fits all customized platform that can cut across all regions
• The inconsistency in the services of healthcare providers.

DigiPharm Solution
A solution that Digipharm proposes are new methods for crowdfunding medical services that are innovative on a platform called the Evolve . They will enable this funding through initial coin offering and digital assetization to support pre-clinical studies, research, ex-vivo studies and early proof of concept research.

• Smart contracts – these are pieces of code that are self executing and facilitate, enforce or verify the conditions/terms of an agreement that has been predetermined.
• Private Channels - secure channels on the DPH private blockchain will be used to transmit sensitive data and comply with all protection and regulatory laws.
• Digital Identity Services - this will be used to create profiles for stakeholders and patients who are enrolled and still maintain their anonymity within each platform.

Digipharms’ solutions aim to accelerate the much-needed restructuring of healthcare delivery systems to a value-based approach.

HOW DIGIPHARM WORKS
There are some basic terms you need to understand to have a general view of how Digipharm works. They are;
Innovative Pricing
There are many names that have been given to this term; value-based pricing, risk-sharing schemes, pay for performance, etc. Regardless of the name it goes by, the meaning remains the same. It is an approach that have the potential to solve the funding challenges often associated with new drugs.
What’s more, based on measurable outcomes of a patient, i.e. disease progression and overall survival, it can be structures such that the healthcare system bears the cost for the value delivered by the drug when used by patients.

For example, if we are not entirely sure of how many cancer patients will survive for at least six months when starting a treatment. An agreement between the healthcare system and manufacturer could be used to set a base price for the treatment. This base price is increased for every patient that lives for at least six months and decreased for every patient that does not.
This is the most effective pricing scheme where risk and uncertainty between healthcare system and manufacturer is present. It saves cost and improve patient outcomes.
There is one question now; how does Digipharm implement this value-based pricing? The answer can be summarized into two words, Reimburse Platform.

Reimburse Platform
This is a platform that is designed to help payers and manufacturers negotiate pricing agreements. This can range from personalized schemes that are based on a surrogate outcome, to a wider access agreement.
Using patient treatment and outcome data, Reimburse Platform expedites, integrates, coordinates and delivers a healthcare system that focuses on the improvement of patient outcomes. At the same time, accelerating payment for value mechanism between the payers and manufacturers through a peer to peer technology.
The benefits of the Reimburse Platform extend to all the parties involved.

The patient enjoys;
• Faster access to high cost drugs
• Personalized and patient centric healthcare
• Pay less for drugs that provide less benefit
• Benefit from increased competition between manufacturers
• Benefit from accelerated access to innovative therapy
Benefits to payers and manufacturers are numerous as well.

The Insight Platform
The Insight platform is all about data collection. It involves the extraction of anonymized patient level data, including genomic data. The goal is to prepare for a future healthcare market that is value-based and data driven. What’s more, patients will no longer have to worry about their privacy or data security since it is encrypted on the blockchain.

With Insight platform, patients get to enjoy;
• Ability to access up-to date and reliable health information
• Benefit from evidence-based care
• Custodianship and ownership of their own data
• Facilitates personalized & patient centric healthcare
• Incentives for data contribution
• Security and privacy of data transfer
There are other benefits enjoyed by payers and manufacturers as well.

The refund platform uses automated "smart contracting" elements, enabling the application of a real-time model flexible pricing system and access to patients between healthcare providers, healthcare payers and information systems and administrative infrastructure involving organizations will eliminate the need for manual data handling and processing prices.Platform rebates significantly reduce operating costs associated with implementing value-based pricing systems and potentially changing drug prices and delivering health services as we know them today.The terms of the personal contracts received will be encrypted on the Reimburse platform through an accessible and automated user interface.implementation when agreement conditions are met. The replacement will also make the implementation of various conditions in the same deal price as the use of smart technology contracts, thereby providing more active and personal pricing solutions while passing through the single connection infrastructure barrier.The dynamic nature of health care and replacement systems allows manufacturers to manage and monitor their budgets more efficiently than the possibility of current comprehensive contract prices will not lead to the use or further costs incurred if a detailed deal is implemented by the current system.For example, it is possible to receive a 50% return of treatment costs after 6 months of patient survival and 75% of treatment costs ranging from 6 to 9 months and then 100% post-administration care costs, based on frequency of side effects, disease indicators and hospitalization which is slower for treatment, with additional additional management burden.

The private nature of patient data and pricing agreement between stakeholders and requires a secure channel. Therefore, all sensitive information would be transmitted on Digipharm private blockchain such that it meets all compliance, regulatory and data protection laws.

Digital Identity Services
It is necessary to protect the privacy of the users. As such, Digipharm uses the digital services that the blockchain provides to create profiles for patients and other stakeholders that are enrolled, without compromising their anonymity.

Security Maintenance
Digipharm networks, including the endpoints will be constantly monitored for security anomalies. If any is suspected, a dedicated investigation protocol would be initiated.

DIGIPHARM TOKENS (DPH)
The tokens are expected to be used to access the Digipharm platform. Although the fees will be determined in US Dollars, the quantity of token charged depends on the level of access a user requires. It ranges from manufacturer, patient, provider to payer. The form of interaction required is another factor to consider. However, the token required for this (interaction) is subject to change.
Characteristics of Digipharm Token
The token has a maximum supply of 100,000,000 which are ERC20 compliant. With a ticker code of DPH and decimal place of 18, the Digipharm token price is set at 1.00 USD.

The pre-sale features a total of 15,000,000 DPH at a base price of 1.00 USD and a discount of 35 percent. It is expected to last four weeks. However, the main sale features 50,000,000 DPH. The remaining 35,000,000 DPH is reserved for;
• Referrals/Bounties
• Reserve/Product development
• Team/Partners
According to the whitepaper, any unsold token would be burnt.

Sources
Website: https://www.digipharm.ch/
Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf
Facebook: https://www.facebook.com/digipharmteam/
Twitter: https://twitter.com/DigipharmTeam
Linkedin: https://www.linkedin.com/company/11360677/
Medium: https://medium.com/@digipharm
Telegram: https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ
Youtube: https://www.youtube.com/channel/UCtZuSfZBVdKErQtbO9Ql4Pg
Author: https://bitcointalk.org/index.php?action=profile;u=1688466